Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 761-767

  Schmidt, Bernhard M W ^a   Georgens, Anette C ^a   Martin, Nicole ^a   Tillmann, Hanns Christian ^a   Feuring, Martin ^a   Christ, Michael ^a   Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; DOBUTAMINE; ESMOLOL; PHENYLEPHRINE; PLACEBO;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HEART RATE VARIABILITY; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; IMPEDANCE CARDIOGRAPHY; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ALDOSTERONE; BLOOD PRESSURE; CARDIAC OUTPUT; CREATININE; CROSS-OVER STUDIES; DOBUTAMINE; DOUBLE-BLIND METHOD; ELECTROLYTES; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; PHENYLEPHRINE; PLACEBOS; PROPANOLAMINES; RENIN-ANGIOTENSIN SYSTEM; UREA; VASCULAR RESISTANCE;

EID: 0035093262     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.2.761     Document Type: Article

References (28)

1. Hormones and hemodynamics in heart failure
2. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
3. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators
4. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial
6. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
7. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
8. Angiotensin II and sympathoactivation in heart failure
9. Rapid cardiovascular action of aldosterone in man
10. Short term cardiovascular effects of aldosterone in healthy male volunteers
11. Specific, nongenomic actions of steroid hormones
12. Non-classical receptors for aldosterone in plasma membranes from pig kidneys
13. The inositol-1,4,5-triphosphate system is involved in rapid nongenomic effects of aldosterone in human mononuclear leukocytes
14. Immediate effects of aldosterone on diacylglycerol production and protein kinase C translocation in vascular smooth muscle cells
15. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: Subcellular localization of calcium release by single cell imaging
16. Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells
17. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells
18. Klinisch-experimentelle untersuchungen über den einfluss von aldosteron auf hämodynamik und gerinnung
19. Aldosterone blunts the baroreflex response in man
20. A dose-response study of phenylephrine in critically ill, septic surgical patients
21. Continuous measurement of hemodynamic alterations during pharmacologic cardiovascular stress using automated impedance cardiography
22. A new stroke volume equation for thoracic electrical bioimpedance: Theory and rationale
23. Spectral analysis of the heart rate variability signal
24. Impaired baroreflex function and arterial compliance in primary aldosteronism
25. Aldosterone blockade improves heart rate variability, improves collagen turnover and reduces early morning increase in heart rate in chronic heart failure
26. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation
27. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells
28. Role of 11β-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries